Forms and applications
New service developments
For applications for minor formulary changes, please use the ‘Request for Amendments to Existing Formulary Choice or a Medicine Switch’ form.
The aim of Pan Mersey Area Prescribing Committee is to make recommendations on the use of medicines across Merseyside. In order to meet this responsibility the Board has incorporated four subgroups, one of which is the new medicines subgroup. The purpose of this subgroup is to undertake horizon scanning in order to prioritise and plan for the introduction of new medicines, changes in patent and licence of existing medicines, and implementation of national guidance which has the potential for significant clinical or financial impact on health economy.
The new medicines subgroup considers all applications for the introduction of new medicines and by using systematic processes, will review all drugs fully before deciding whether the drug should be introduced onto our formulary. The application for a new medicine involves an approved request being received from a clinician, going through the hospitals Drug and Therapeutic Committees and if applicable, a full review being conducted by our Pharmacists to ascertain whether the requested the medicine is viable in terms of cost, effectiveness and most of all, patient safety, using evidence from NICE, EMEA and other reliable medical sources.
NHS Halton CCG
Becky Birchall email@example.com
NHS Knowsley CCG
Carrie Barton firstname.lastname@example.org
NHS Liverpool CCG
Peter Johnstone email@example.com
NHS Southport and Formby CCG
Kay Walsh firstname.lastname@example.org
NHS South Sefton CCG
Kay Walsh email@example.com
NHS St Helens CCG
Les Schofield firstname.lastname@example.org
NHS Warrington CCG
Jenny Lunn email@example.com
NHS West Lancashire CCG
Nicola Baxter firstname.lastname@example.org
NHS Wirral CCG
Abigail Cowan email@example.com
Alder Hey Hospital Children's NHS Trust
Mo Azar firstname.lastname@example.org
Bridgewater Community Healthcare NHS Foundation Trust
Jimmy Cheung email@example.com
Liverpool Heart and Chest Hospital NHS Foundation Trust
Danny Forrest firstname.lastname@example.org
Liverpool University Hospitals NHS Foundation Trust (Aintree, Royal, and Broadgreen)
Jenny Bellis email@example.com
Liverpool Women's NHS Foundation Trust
Daniel Collins firstname.lastname@example.org
Mersey Care NHS Trust
Agatha Munyika email@example.com
North West Boroughs Healthcare NHS Foundation Trust
Kerry Lawton firstname.lastname@example.org
Southport and Ormskirk Hospital NHS Trust
Hannah Al-Jaffar email@example.com
St Helens and Knowsley Teaching Hospitals NHS Trust
Mike Welsby firstname.lastname@example.org
The Walton Centre
Eleri Phillips email@example.com
Warrington and Halton Hospitals NHS Foundation Trust
James Parker james.parker14@.nhs.net
Wirral University Teaching Hospitals NHS Foundation Trust
Alison Evans firstname.lastname@example.org
Individual funding requests
An Individual Funding Request (IFR) is a request to fund healthcare for an individual who falls outside the range of services and treatments that Pan Mersey Clinical Commissioning Group (CCG) have agreed to commission.
An IFR is only regarded as such when a case can be set out by a patient’s clinicians that they have exceptional clinical circumstances. Here you will find the definition of exceptionality as detailed in the Individual Exceptional Funding Requests for Clinical Interventions Policy.
The patient is significantly different to the general population of patients with the condition in question and the patient is likely to gain significantly more benefit from intervention than might normally be expected for patients with that condition.
Dr Henrietta Ewart
The following information explains how CCGs across the Pan Mersey health economy makes decisions about providing treatments that are not normally available through the National Health Service (NHS).
Like any other organisation, the NHS has limited resources and CCGs have a duty to manage them to a robust process.
This means they have to:
- look at evidence for the safety and effectiveness of any treatment and
- ensure that the services they pay for will give patients the greatest health gains from the finite resources have available.
There are a set of recognised principles which are used in the NHS to guide commissioning decisions on individual treatments. There are some treatments that are not routinely funded and as such CCGs have policies on particular drugs or treatments. These clinical commissioning policies are agreed with other CCGs in Cheshire and Merseyside, are reviewed regularly and are available on the Pan Mersey website Internal hyperlink.
The IFR Team will validate requests in line with the respective CCGs’ commissioning policies.
All personal Information received is treated in the strictest confidence and used according to the data-protection laws.
The IFR Team will consider whether a case meets the respective CCG policy criteria and will make a decision. On occasions a case may need to be discussed by the Individual Funding Panel who meet regularly. The panel consists of representatives from the IFR Team who will present your case as well as clinicians and senior managers.
There are times when an IFR may be refused and this is always a difficult situation. A detailed response on the reason for the decision will be provided including the criteria considered by the IFR panel.
- The IFR clinical triage team will screen it against the respective CCG’s local policies and a decision will be made.
- If the triage team cannot make a decision, further information may be requested.
- On receipt of further information requested the triage team will then review this request again and make a decision if possible.
- If the triage team cannot make a decision, your request will be considered by the Individual Funding Panel.
- If the person concerned or their referring clinician thinks the IFR team have not followed the correct process to reach their decision, or you feel they did not consider everything relevant when they made the decision, your referring clinician can appeal by writing to say why.
The IFR team makes its decision on whether to fund new technologies and medicines by assessing the clinical effectiveness of treatments (do they work and what are the benefits when compared with existing treatments?) and their cost effectiveness. Where there are significant financial implications for a CCG but proven health benefits, the final decision rests with the Governing Body of the respective CCG.
The IFR team also receives requests from health professionals to fund a treatment that is not normally commissioned by the CCG. If the request could apply to a number of patients, the decision is referred to the CCG to consider the development of a relevant policy. Otherwise, the decision the panel needs to make is whether the patient is clinically exceptional to our policy (as defined above) and whether it is fair and equitable to offer this treatment to one individual when it is not routinely available to others.
IFR’s are dealt with by Midlands and Lancashire Commissioning Support Unit who provide the service on behalf of all CCGs across Cheshire and Merseyside.
Patients are unable to submit IFR’s. However, if the patient’s treating clinician believes that their case is clinically exceptional then they can submit a request (and all relevant clinical information to support the application) using the relevant IFR form which can be accessed on the links below.
For non-contract activity treatment funding requests ONLY where local or national guidance exists and routinely funded by CCGs within the provider’s local health economy:
In the event that you are unable to forward the application from a secure email address, the application can be posted to:
1829 Building – Mail Account
Individual Funding Request Team
Countess of Chester Hospital NHS Foundation Trust
The decision to issue a Pan Mersey policy statement recommendation is made by the Pan Mersey Area Prescribing Committee. It does this after consideration of the recommendations of its sub-committees, and in consultation with its stakeholders.
In line with good practice recommendations that a clinician is best placed to submit a formal appeal on behalf of their patient population, the appeals process is open to clinicians (GPs, Consultants, Senior Nurses, Senior Pharmacists or non-medical independent prescribers) with relevant expertise and who work within the Pan Mersey Health Economy. It exists to give those clinicians who feel that that the Pan Mersey policy statement recommendation may result in a compromise in care to patients, an opportunity to make their case for the recommendation to be amended.
Use this form to make an appeal against a policy statement recommendation issued by the Pan Mersey APC.
You can use this form if you are a clinician (GP, Consultant, Senior Nurse, Senior Pharmacist or non-medical independent prescriber) with relevant expertise and who work within the Pan Mersey Health Economy, and for the following reasons:
- You are appealing against a decision by the Pan Mersey APC to accept, reject or position an application for a specific medicine because vital evidence was not considered or incorrect information was considered in the original application.
- You are appealing against a decision made by the Pan Mersey APC because its procedures and policies were not followed.
You cannot use this form if you are appealing against a decision because new evidence has come to light since the original decision was made. In this case, a new business case, highlighting the new evidence, should be made.